CRPC-reactive protein, CATcatalase, MPOmyeloperoxidase, FOXferroxidase, IMAischemia modified albumin, PON-1paraoxonase 1, TOStotal oxidant status, TAStotal antioxidant status, MDAmalondialdehyde, 8H2D8-hydroxy 2-deoxyguanosine, AOPPadvanced oxidation protein products, NADPH oxidasenicotinamide adenine dinucleotide phosphate, ROSreactive oxygen species, GSH-Pxglutathione peroxidase, GSHglutathione, TrxRthioredoxin reductase, FRAPferric reducing ability of plasma, ASarylesterase, OSIoxidative stress index, Pxsalivary peroxidase, SODsuperoxide dismutase, AGEadvanced glycation end-products, LOOHlipid hydroperoxides, OxLDLoxidized low-density lipoproteins, NOnitric oxide, 8-OHdG8-hydroxy guanosine, iNOSinducible nitric oxide, GSH-Rglutathione reductase, MSmetabolic syndrome, 25-OH-vitD25-hydroxy-vitamin D, ADAadenosine deaminase, s-TICserum trypsin inhibitory capacity, TBAthiobarbituric acid, ADatopic dermatitis, TPXtotal peroxide concentration, PCCprotein carbonyl compounds, PPpyrrolized protein, GSSGoxidized glutathione, HOhemoxygenase, TBtotal bilirubin, DBdirect bilirubin, IBindirect bilirubin, Cucopper, Feiron, Trftransferrin, Cpceruloplasmin, AuAb-oxLDLautoantibodies anti-oxidized LDL, SHthiol, SSdisulfide, CADcoronary artery disease, IL-6interleukin-6, Ab anti-CELanti-carboxyethyllysine antibodies, Ab anti CMLanti-carbocymethyllysine antibodies
NO is generated by three different isoforms of the enzyme nitric oxide synthase (NOS), namely, inducible iNOS, endothelial eNOS, and neuronal nNOS
ACh regulates Ca 2+ levels and transcription factor expression through muscarinic receptors, while acetylcholinesterase (AChE) promotes the breakdown of ACh
[0385] The anti-ALPP/ALPPL2 antibodies described herein can be coupled directly to the radio-opaque moiety (e.g., at an available cysteine) or they can be attached to a "package" (e.g., a chelate, a liposome, a polymer microbead, a nanoparticle, etc.) carrying, containing, or comprising the radio-opaque material, e.g., as described below
